Inventor
LIANGQIN GUO
Inventor
US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes27%
C07DHeterocyclic compounds27%
C07CAcyclic or carbocyclic compounds7%
C07KPeptides7%
C07BGeneral methods of organic chemistry3%
PatentTitleYear
12,576,087Aryloxypiperidine pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors202612,264,134Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors202512,246,0084-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels202512,178,842PCSK9 antagonist compounds202412,152,019Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors202412,091,405Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors202412,065,438Substituted tricyclic compounds as indoleamine 2,3-dioxygenase inhibitors202411,484,565PCSK9 antagonist compounds202211,478,461[1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors202211,352,320Substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to MERCK SHARP & DOHME LLC (9)· patent assignee history
2022Patents assigned to MERCK SHARP & DOHME (2)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME LLC | 9 | 2022–2026 |
| MERCK SHARP & DOHME | 2 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 10 | 2022–2026 |